Markets India

Lab-grown diamond manufacturer Anjali LabTech Ltd has resubmitted updated draft papers to India’s Securities and Exchange Board of India (SEBI) for an Rs 1,225 crore IPO, aiming to fund expansion and debt reduction. The offering includes a Rs 925 crore fresh share issue, a Rs 300 crore promoter-led Offer For Sale (OFS), and a pre-IPO placement of up to Rs 185 crore. The move underscores the company’s strategy to scale its vertically integrated operations in India’s rapidly growing lab-grown diamond sector.

Anjali LabTech, a vertically integrated lab-grown diamond (LGD) manufacturer based in Surat, Gujarat, has filed updated draft papers with SEBI for an Rs 1,225 crore IPO. The offering comprises a fresh share issue of Rs 925 crore, a promoter-led OFS of Rs 300 crore, and a pre-IPO placement of up to Rs 185 crore. The company, which operates seven manufacturing facilities in Surat—a hub accounting for over 90% of India’s LGD production—plans to use proceeds for capital expenditure, debt repayment, and corporate development. The filing follows SEBI’s approval in February 2026 to launch the IPO.

The IPO’s structure reflects Anjali LabTech’s focus on strengthening its manufacturing capabilities and reducing reliance on debt. Proceeds will fund the installation of MPCVD machines for in-house diamond growth, construction of a corporate headquarters, and operational expansion. The pre-IPO placement, if executed, could reduce the fresh issue size by up to Rs 185 crore. The company’s vertically integrated model, spanning the entire LGD value chain, positions it to capitalize on India’s growing demand for sustainable gemstones.

The IPO highlights Anjali LabTech’s strategic push to solidify its leadership in the LGD sector. By leveraging Surat’s dominance in diamond production, the company aims to enhance production capacity and operational efficiency. The OFS and pre-IPO placement also signal confidence in its valuation and growth prospects. However, the success of the offering hinges on market demand for its shares and the company’s ability to execute its expansion plans effectively.

The IPO, approved by SEBI in February 2026, will proceed with the launch of the public offering. If the pre-IPO placement is executed, the fresh issue size will be reduced accordingly.

Anjali LabTech’s Rs 1,225 crore IPO aims to fund expansion and debt reduction, reinforcing its position in India’s lab-grown diamond sector. The outcome will depend on market demand and the company’s ability to scale operations, with the pre-IPO placement and OFS serving as key indicators of investor confidence.

Topics: Lab-Grown Diamonds, IPO Filings, SEBI Regulation, Diamond Manufacturing, Vertical Integration, Surat Economy, Financial Markets, Corporate Expansion

#AnjaliLabTech, #LabGrownDiamonds, #IPOFiling, #SEBIApproval, #SuratEconomy, #CorporateExpansion

Source: ET Markets